Pfizer Osake

Pfizer Termiini P/E

Forward P/E -suhde yhtiöstä Pfizer (PFIZER.NS) 18.8.2026 päivämäärällä on 28,74. Edellisenä vuonna Forward P/E -suhde oli 40,02 — muutos −28,17 % (matalampi).

Termiini P/E

28,74

YoY

−28,17%

Viimeksi päivitetty:

Forward P/E -suhde yhtiöstä Pfizer on 2026 28,74 . Forward P/E -suhde yhtiöstä Pfizer oli 2025 40,02 . Se laskee −28,17% matalampi edelliseen vuoteen verrattuna.
Access this data via the Eulerpool API

Pfizer Osakeanalyysi

Mitä Pfizer tekee? Pfizer Ltd is a global biopharmaceutical company based in New York City, USA. The company was founded in 1849 by cousins Charles Pfizer and Charles Erhart, and has achieved numerous milestones in the pharmaceutical industry during its 170-year history. Pfizer's business model is based on the research, development, production, and distribution of innovative drugs and vaccines for a variety of diseases. With a diverse portfolio of products, the company's range extends from drugs for cancer, inflammation, and immunology to neurological and cardiology conditions. Pfizer is a global leader in the development of cancer drugs and has achieved groundbreaking research successes in recent years. Key divisions of the company include oncology, pain management, cardiology, and neurology. Pfizer places great emphasis on putting patients and their needs at the center and works closely with medical professionals, patient groups, and authorities to ensure the best possible patient care. Pfizer is a leading provider of vaccines and has achieved significant breakthroughs in the development of COVID-19 vaccines in recent years. In December 2020, the company was one of the first worldwide to bring a vaccine against the coronavirus to market, making a significant contribution to the fight against the pandemic. In addition to drug research and development, Pfizer is also heavily involved in corporate social responsibility. The company is committed to sustainable development and continuously works to reduce its carbon footprint. The Pfizer Foundation also supports numerous nonprofit organizations and projects in the areas of health, education, and environmental protection. Among Pfizer's most well-known products are medications such as Viagra, Lipitor, and Lyrica, as well as the COVID-19 vaccine Comirnaty. Pfizer has offices in over 150 countries and employs over 90,000 people worldwide. Like any global company, Pfizer faces challenges. The company is often criticized for high drug prices and the availability of medications in developing countries. However, Pfizer actively advocates for access to affordable healthcare and delivers drugs and vaccines to all regions of the world. Overall, Pfizer is a company of great importance in the global healthcare industry. Through its research and development of innovative drugs and vaccines, the company contributes to improving the quality of life for millions of people worldwide. Pfizer on yksi Eurpooliin suosituimmista yhtiöistä.

Usein kysytyt kysymykset Pfizer osakkeesta

Yhtiön Pfizer Forward P/E -suhde on 28,74 vuonna 2026.

Forward P/E -suhde yhtiöstä Pfizer muuttui arvosta 40,02 arvoon 28,74, mikä edustaa −28,17 % muutosta. Arvo on matalampi kuin edellisenä vuonna.

Eurpoolissa voit löytää Forward P/E -suhde Pfizer:n täydellisen historiallisen kehityksen vuodesta 2006 lähtien – vuotuisten arvojen, kaavioiden ja yksityiskohtaisen analyysin kanssa.

Forward P/E käyttää arvioituja tulevia voittoja osakkeen arvostukseen. Pienempi forward P/E peräkkäiseen P/E:hen verrattuna viittaa analyytikkojen odottavan tuloksen kasvua.

Arvioidakseen Forward P/E -suhde:n, on olennaista verrata sitä saman alan ja sektorin kilpailijoihin. Eulerpoolissa voit löytää suoria alan vertailuja Forward P/E -suhde:lle.

"Hyvä" vaihtelee alan ja yrityksen kehitysvaiheen mukaan. Eulerpoolissa voit verrata Forward P/E -suhde:n Pfizer alan vertaisiin ja alan keskiarvoon arvioidaksesi houkuttelevuuden.

Access this data via the Eulerpool API

Arvostus — Pfizer

Kaikki tunnusluvut — Pfizer